Media Releases

The prevalent, highly drug-resistant new STI nobody’s testing for

May 24, 2016

Global News | May. 24, 2016

Researchers have found the first evi­dence of sex­u­al­ly trans­mit­ted infec­tion Mycoplas­ma gen­i­tal­i­um in Cana­da. It’s high­ly preva­lent, inor­di­nate­ly drug-resis­tant, and clin­ics aren’t test­ing for it — until recent­ly there was no stan­dard­ized test avail­able. Uni­ver­si­ty of Toron­to epi­demi­ol­o­gist Dionne Gesink co-authored a paper pub­lished in Cana­di­an Fam­i­ly Physi­cian ear­li­er this year doc­u­ment­ing the first proof the increas­ing­ly com­mon STI is pro­lif­er­at­ing in Cana­da — in Toron­to, specif­i­cal­ly. Read more.